News
The European Investment Bank and the European Commission announced on October 13 that they will provide up to €95 million in blended financing to the German biotechnology company BioNTech to promote the production of mRNA vaccines at its production facility in Kigali, the capital of Rwanda
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments